Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria
Launched by WORLD HEALTH ORGANIZATION · Oct 7, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving contraceptive counseling services in Pakistan and Nigeria. The goal is to create a set of counseling techniques that will help women make better decisions about their contraceptive options. By doing this, the study aims to empower women to take control of their reproductive health and ensure they have access to the contraceptives they need.
To participate in this trial, women must be visiting a family planning clinic with the intention of either using contraception for the first time, switching methods, resuming after a break, or stopping a current method. It's important that they plan to continue their follow-up visits during the study. Participants will receive support and information to help them make informed choices about their contraceptive options. The trial is not yet recruiting participants, but it is designed to provide valuable insights into how to better support women's health needs.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Client comes to the family planning clinic with the intention to 1.a. use contraception for the first time in her life (new user), or 1.b. switch from a contraceptive method to another one (switching user), or 1.c. resume a method after not using any in the prior three months (lapse user), or 1.d. discontinue a modern method (discontinuing user);
- • 2. Client is not coming for the resupply of a currently used method, such as pills or injectables;
- • 3. Client has the intention to continue her follow-up at the health center during the duration of study follow-up;
- • 4. Client does not participate in another study; and
- • 5. Client provides informed consent.
- Exclusion Criteria:
- • Not willing to participate in the complete duration of the trial
About World Health Organization
The World Health Organization (WHO) is a specialized agency of the United Nations dedicated to promoting global health and well-being. As a leading authority in public health, WHO conducts and sponsors clinical trials to advance medical knowledge, develop effective health interventions, and address pressing health challenges worldwide. With a commitment to evidence-based research, WHO collaborates with international partners, governments, and health organizations to ensure that clinical trials adhere to rigorous ethical standards and contribute to the improvement of health outcomes, particularly in underserved populations. Through its extensive network and expertise, WHO plays a pivotal role in shaping health policies and practices on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported